Non-small Cell Lung Cancer — Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients
Citation(s)
A Randomized,Double-blind,Multicenter Phase III Trial to Evaluate the Safety and Efficacy of Icotinib and Gefitinib in Advanced NSCLC Patients Previously Treated With Chemotherapy